What is Genpact's cash and cash equivalents, end of period?

Genpact (G) reported cash and cash equivalents, end of period of $578.08M in Q1 2026.

How has Genpact's cash and cash equivalents, end of period changed year-over-year?

Genpact's cash and cash equivalents, end of period increased by 2.9% year-over-year, from $561.62M to $578.08M.

What is the long-term trend for Genpact's cash and cash equivalents, end of period?

Over 2 years (2023 to 2025), Genpact's cash and cash equivalents, end of period has grown at a 20.9% compound annual growth rate (CAGR), from $583.67M to $853.84M.

Genpact G Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

Phillips 66PSX

$5.15B+246%

Arthur J. GallagherAJG

$8.48B-61.9%

3MMMM

$3.73B-41.1%

eBayEBAY

$4.23B+1.9%

American Financial GroupAFG

$1.35B+6.0%

Erie Indemnity CompanyERIE

$268.62M+3.2%

Other financials

Income statement

See full

Revenue$1.3B+6.7%

Gross profit$471.7M+9.9%

Operating income$198.6M+8.1%

Net income$148.0M+13.1%

EPS (diluted)$0.86+17.8%

Balance sheet

See full

Cash & equivalents$578.1M+2.9%

Total debt$1.4B-4.9%

Total equity$2.5B+0.9%

Total assets$5.6B+14.8%

Cash flow

See full

Operating cash flow-$23.5M-158%

CapEx$23.9M+8.9%

Free cash flow-$47.5M-357%

Valuation

See full

Market cap$4.79B-28.5%

Profitability

See full

Gross margin36.3%+0.8pp

Operating margin14.8%-0.1pp

Net margin11%+0.2pp

FCF margin13%+0.6pp

Returns & leverage

See full

Return on equity23.1%+0.9pp

Debt / equity0.6×0.0×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by Genpact in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Genpact’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Genpact's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Genpact's cash and cash equivalents, end of period?: Genpact (G) reported cash and cash equivalents, end of period of $578.08M in Q1 2026.
How has Genpact's cash and cash equivalents, end of period changed year-over-year?: Genpact's cash and cash equivalents, end of period increased by 2.9% year-over-year, from $561.62M to $578.08M.
What is the long-term trend for Genpact's cash and cash equivalents, end of period?: Over 2 years (2023 to 2025), Genpact's cash and cash equivalents, end of period has grown at a 20.9% compound annual growth rate (CAGR), from $583.67M to $853.84M.